Short description
A diagnostics platform that makes liquid biopsies a reality in cancer care
Description
With the use of Hedera Dx's liquid biopsy solution, hospital labs will be able to conduct clinically useful liquid biopsies on their own. This will greatly simplify tumor profiling. It is difficult to accomplish IVD compliance, privacy infrastructure, and validation, and even if these challenges are overcome, the current software workflows are inefficient to use and lack key capabilities.
Hedera Dx was established on July 1, 2021 in Epalinges, Vaud.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Epalinges, Vaud, Switzerland, Europe
Founded on
July 1, 2021
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Uh Ohhhh, Noaccess, Cannot Access, Noaccessforu, Noaccess, Noaccess
Sign in for full access
Founders
Christian Meisel, Damien Lapray, Tommi Lehtonen